Oxford, United Kingdom

Norma Masson


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Norma Masson

Introduction

Norma Masson is a notable inventor based in Oxford, GB. She has made significant contributions to the field of biochemistry, particularly in the study of 2-oxoglutarate dependent oxygenases. Her work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Norma Masson holds a patent titled "Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same." This patent describes a method for identifying agents that modulate the activity of 2-oxoglutarate dependent oxygenases. The method involves contacting the enzyme with a test agent in the presence of a substrate that includes ankyrin repeat proteins, allowing for the determination of hydroxylation of the substrate.

Career Highlights

Norma is associated with Isis Innovation Limited, where she applies her expertise in biochemistry to advance research and development. Her innovative approach has led to the creation of valuable methodologies that enhance our understanding of protein modulation.

Collaborations

Throughout her career, Norma has collaborated with esteemed colleagues, including Christopher Joseph Schofield and Kirsty Sarah Hewitson. These partnerships have fostered a collaborative environment that promotes scientific discovery and innovation.

Conclusion

Norma Masson's contributions to the field of biochemistry through her patent and collaborative efforts highlight her role as an influential inventor. Her work continues to pave the way for advancements in understanding protein interactions and their implications in various biological contexts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…